Compensation 990
OrganizationsEmployeesBoard MembersGrantsContractorsTop RankingsPricing

Stay updated on 990 organization compensation

© Civic Register LLC

Compensation 990 is an independent service that uses public IRS Form 990 filings as its source data. We clean and standardize this information, but the original filings may contain errors or omissions. Years on this site refer to the organization’s fiscal year end date on the filing.

About•Report a discrepancy•Your privacy choices
Organizations Medical Research ALS Therapy Development Foundation Inc.

ALS Therapy Development Foundation Inc.

Fiscal year ending 2022. Filed on September 8, 2023.

480 Arsenal Street Suite 201
Watertown, Massachusetts 02472

ALS Therapy Development Foundation Inc. (EIN: 04-3462719), also known as ALS Therapy Development Institute, has filed an IRS Form 990 since at least fiscal year 2016. In its fiscal year 2022 IRS Form 990 filing, ALS Therapy Development Foundation Inc., a 501(c)(3) charitable organization, reported compensation for 6 out of 59 total employees. Among the employees shown here, the average compensation is $188,539. The highest compensated employee at ALS Therapy Development Foundation Inc. is Fernando Vieira with fiscal year 2022 compensation of $330,812. ALS Therapy Development Foundation Inc. changed its name from ALS Therapy Development Foundation Inc. D/B/a ALS Therapy Development Institute in 2022.

Revenue, expenses, and employee compensation

Revenue

$11,364,169

Expenses

$9,829,539

Employee compensation

$4,486,981
Revenue, expenses, and employee compensation over time

Reported Compensated Employees

Fernando Vieira
CEO / CSO
$330,812
$315,125 No related comp$15,687
Alan Gill
Vice President, Research
$178,934
$170,654 No related comp$8,280
Matvey Lukashev
Vice President of Translation Sciences
$173,583
$160,332 No related comp$13,251
Carol Hamilton
Vice President, Development
$156,479
$148,199 No related comp$8,280
Kyle Denton
Director, CELL Biology
$154,691
$134,069 No related comp$20,622
Theo Hatzipetros
Director of Pharmacology
$136,737
$130,026 No related comp$6,711

Benchmark Employee Compensation

Non-Employee Board Members

Alexander Cappello
Board Member
Andrew Niblock
Board Member
Augie Nieto
Chairman and Board Member
Dr Spiros Jamas Scd
Board Member
Dr Stanley H Appel, M.D.
Board Member
James Allen Heywood
Board Member
Jenny Dwyer
Board Member
John B Heywood Ph.D. Scd
Board Member
Julie Swan
Board Member
Kent Jackson Bransford, M.D.
Board Member
Lynne Nieto
Board Member
Mike Smith
Board Member

Contractors

Insource Services Inc.
Finance HR and IT
$488,389
Lathrop and Gage LLP
Legal
$112,260

Mission Statement

WE ARE COMMITTED TO CREATING AND LEADING A TRANSPARENT COLLABORATIVE RESEARCH PROCESS THAT INVOLVES ALS PATIENTS TODAY AND HONORS THOSE WHOSE JOURNEY WITH THIS DISEASE HAS ENDED. WE ARE GUIDED BY PASSION, LOVE AND THE SPIRIT OF ENTREPRENEURSHIP UPON WHICH WE WERE FOUNDED.

Revisions to this organization profile

June 26, 2025:
2024 ALS Therapy Development Foundation Inc. 990 filed
June 25, 2024:
2023 ALS Therapy Development Foundation Inc. 990 filed
September 8, 2023:
2022 ALS Therapy Development Foundation Inc. 990 filed

Get an email when new compensation information is released for ALS Therapy Development Foundation Inc.

Be the first to know when new IRS Form 990 data is published for this organization.

Related Jobs

View more jobs
Powered by Talroo
Report a discrepancy →